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I. INTRODUCTION 
Indiana State District Council v. Omnicare, Inc.1 is a case about 
opinions—and what it takes to hold companies liable for incorrect ones. In 
Omnicare, a three-judge panel of the Sixth Circuit held that plaintiffs need 
only plead objective falsity of an opinion in a registration statement to state a 
claim under section 11 of the Securities Act.2 The panel’s holding runs 
contrary to popular opinion: every other circuit court of appeals that has 
addressed the issue requires plaintiffs to plead both objective falsity and the 
defendant’s subjective disbelief.3 Omnicare should be reversed because it rests 
on deficient reasoning and will have adverse practical consequences. 
II. THE SIXTH CIRCUIT’S DECISION 
In connection with its December 2005 public stock offering, Omnicare 
submitted a registration statement to the Securities and Exchange Commission 
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 1 Ind. State Dist. Council of Laborers v. Omnicare, Inc., 719 F.3d 498 (6th Cir. 
2013), cert. granted, 82 U.S.L.W. 3242 (U.S. Mar. 3, 2014) (No. 13-435). 
 2 Id. at 505. 
 3 See MHC Mut. Conversion Fund, L.P. v. Sandler O’Neill & Partners, L.P., 761 
F.3d 1109, 1113 (10th Cir. 2014); Fait v. Regions Fin. Corp., 655 F.3d 105, 110 (2d Cir. 
2011); Rubke v. Capitol Bancorp Ltd., 551 F.3d 1156, 1162 (9th Cir. 2009). 
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containing opinions about the company’s legal compliance.4 One such opinion 
stated, “We believe that our contracts with pharmaceutical manufacturers are 
legally and economically valid arrangements that bring value to the healthcare 
system and the patients that we serve.”5 That opinion turned out to be 
incorrect, causing Omnicare to settle multiple qui tam lawsuits at a substantial 
financial loss to the company.6 
In January 2006, two pension funds that had purchased stock during 
Omnicare’s public offering filed a class action lawsuit. The amended 
complaint alleged that Omnicare violated section 11 of the Securities Act, 
which provides a cause of action for investors who acquired securities under a 
registration statement that “contained an untrue statement of a material fact or 
omitted to state a material fact.”7 According to the plaintiffs, Omnicare’s legal 
compliance statements were untrue because, at the time they were made, the 
company was receiving unlawful kickbacks and submitting false claims to 
Medicare and Medicaid.8 However, the plaintiffs disclaimed any allegation of 
fraudulent or intentional misconduct.9 The district court dismissed the claim, 
holding that section 11 requires a plaintiff to plead subjective disbelief—that 
is, that the defendant knew its statements were untrue or misleading at the time 
they were made.10 
The Sixth Circuit reversed. Judge R. Guy Cole’s opinion for the panel 
rested primarily on the rationale that section 11 is a strict liability provision. 
Omnicare argued that the provision contains language materially identical to 
section 10(b) of the Securities Exchange Act, and because the Sixth Circuit 
requires plaintiffs to plead subjective disbelief under that section, the same 
standard should govern section 11 claims.11 The panel disagreed, noting that 
section 10(b) and Rule 10b-5 require proof of scienter, whereas section 11 
provides for strict liability.12 The panel held that “once a false statement has 
                                                                                                                     
 4 Omnicare, 719 F.3d at 500–01. 
 5 Omnicare, Inc., Registration Statement (Form S-10) (Dec. 12, 2005). 
 6 One of the largest settlements required Omnicare to pay $98 million for its 
involvement in kickback schemes. Press Release, U.S. Dep’t of Justice, Nation’s Largest 
Nursing Home Pharmacy and Drug Manufacturer to Pay $112 Million to Settle False 
Claims Act Cases (Nov. 3, 2009), http://www.justice.gov/opa/pr/nation-s-largest-nursing-
home-pharmacy-and-drug-manufacturer-pay-112-million-settle-false [http://perma.cc/ UQX5- 
YPPX].  
 7 15 U.S.C. § 77k (2012). 
 8 Brief for Plaintiffs at 19, Omnicare, 719 F.3d 498 (No. 12-5287) (“Omnicare 
violated the Federal Anti-Kickback Statute, assisted pharmaceutical manufacturers in 
promoting drugs for off-label use in violation of the Food, Drug and Cosmetic Act, assisted 
pharmaceutical manufacturers in evading ‘Best Price’ detection in violation of the 
Medicaid Drug Rebate Statute, and violated the federal False Claims Act.”). 
 9 Id. at 14. 
 10 See Ind. State Dist. Council of Laborers v. Omnicare, Inc., No. 2006-26 (WOB), 
2012 WL 462551, at *4–5 (E.D. Ky. Feb. 13, 2012). 
 11 Brief for Defendants at 29, Omnicare, 719 F.3d 498 (No. 12-5287). 
 12 Omnicare, 719 F.3d at 505. 
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been made, a defendant’s knowledge is not relevant to a strict liability 
claim.”13 Consequently, the panel concluded that the district court erred in 
dismissing the claim.14 
The panel also disagreed with Omnicare’s contention that Virginia 
Bankshares, a Supreme Court case involving section 14(a) of the Securities 
Exchange Act, should be interpreted to require section 11 plaintiffs to plead 
subjective disbelief. The panel explained that Virginia Bankshares requires a 
plaintiff to plead objective falsity, and pleading subjective disbelief alone is 
not enough to state a claim under section 14(a).15 The panel reasoned that 
Virginia Bankshares is inapplicable because the Court did not address whether 
plaintiffs are required to plead subjective disbelief.16 The panel further 
determined that Virginia Bankshares has “very limited application to § 11” 
because the Court had assumed knowledge of falsity based on a jury verdict.17 
Thus, according to the panel, nothing in Virginia Bankshares alters the 
outcome that dismissal was improper.18 
  The Omnicare decision runs contrary to popular opinion. Three other 
circuit courts of appeals have addressed the issue, and each has held that 
plaintiffs must allege both objective falsity and subjective disbelief in order to 
survive a motion to dismiss.19 Not surprisingly, Omnicare has drawn uproar 
from the securities defense bar. Some practitioners predict the Sixth Circuit 
will become the “new hotspot” for section 11 litigation,20 while others worry 
the decision will chill voluntary disclosure of opinions in registration 
statements.21 
After the Sixth Circuit denied rehearing en banc, Omnicare took its case to 
the Supreme Court. The Court granted certiorari and heard oral argument on 
November 3, 2014. Counsel for the plaintiffs seemed reticent to defend the 
reasoning of the Omnicare panel during oral argument,22 and it was apparent 
                                                                                                                     
 13 Id. 
 14 Id. at 510. 
 15 Id. at 506. 
 16 Id. 
 17 Id. at 507. 
 18 Omnicare, 719 F.3d at 506. 
 19 See MHC Mut. Conversion Fund, L.P. v. Sandler O’Neill & Partners, L.P., 761 
F.3d 1109, 1113 (10th Cir. 2014); Fait v. Regions Fin. Corp., 655 F.3d 105, 110 (2d Cir. 
2011); Rubke v. Capitol Bancorp Ltd., 551 F.3d 1156, 1162 (9th Cir. 2009). 
 20 James Grohsgal & Amy Ross, The Sixth Circuit—The New Hotspot for Section 11 
Suits, SEC. LITIG. & REG. ENFORCEMENT BLOG (May 29, 2013), http://blogs. 
orrick.com/securities-litigation/2013/05/29/the-sixth-circuit-the-new-hotspot-for-section-11- 
suits/ [http://perma.cc/5S75-2NK4]. 
 21 Brian Mahoney, Securities Defense Bar Has High Hopes Riding on Omnicare, 
LAW360 (Mar. 3, 2014, 8:09 PM), http://www.law360.com/articles/514894/securities-
defense-bar-has-high-hopes-riding-on-omnicare [http://perma.cc/8JB8-Z3TW]. 
 22 As counsel for Omnicare noted, “This is the rarer case in which none of the parties 
is defending the reasoning of the court of appeals below.” Transcript of Oral Argument at 
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that certain Justices do not agree with the holding.23 But it was also evident 
that some Justices are skeptical of Omnicare’s proposed legal standard, which 
would require section 11 plaintiffs to plead both objective falsity and 
subjective disbelief.24 Predictions abound as to how the case will be decided.25 
III. WHY OMNICARE SHOULD BE REVERSED 
The Supreme Court should reverse Omnicare for two reasons. First, the 
holding is based on the deficient rationale that section 11 is a strict liability 
provision. To be sure, the Court has said section 11 imposes a “stringent 
standard of liability,” and plaintiffs “need only show a material misstatement 
or omission to establish [a] prima facie case.”26 This makes sense for 
statements of fact (e.g., historical data) because objective falsity can be 
determined at the time the statements were made. However, strict liability does 
not make sense for statements of opinion (e.g., legal compliance) because 
unlike a fact, an opinion is only untrue if the speaker does not actually believe 
it or if it lacks a reasonable basis.27 Given the difference between facts and 
opinions, it is inappropriate to treat them similarly for purposes of section 11 
liability. 
Furthermore, the Omnicare panel’s reasoning overlooks an important 
aspect of section 11. The prohibition on material misstatements and omissions 
applies to “any part of the registration statement, when such part became 
effective.”28 In other words, whether a statement is untrue or misleading is 
determined at the time the statement was made. Yet the panel’s holding allows 
investors to sue any time the subject matter of an opinion is determined to be 
objectively incorrect, regardless of whether the opinion was sincerely held or 
                                                                                                                     
54, Omnicare, Inc. v. Laborers Dist. Council Constr. Indus. Pension Fund, 82 U.S.L.W. 
3242 (argued Nov. 3, 2014) (No. 13-435). 
 23 For example, Justice Breyer believes the proper pleading standard should consider 
whether there was a reasonable basis as well as the issuer’s state of mind. Id. at 27–28.  
 24 Chief Justice Roberts appeared to be among the skeptics, as he suggested that 
Omnicare’s proposed standard would insulate companies from liability as long as they 
preface statements with the words “we believe.” Id. at 4. 
 25 See, e.g., Richard Booth, Argument Analysis: Justices Seem Likely to Affirm 
Omnicare, SCOTUSBLOG (Nov. 4, 2014, 12:35 PM), http://www.scotusblog.com/2014/11/ 
argument-analysis-justices-seem-likely-to-affirm-omnicare/ [http://perma.cc/HR9V-ZWQH] 
(“Following yesterday’s oral argument, there is not much doubt that the Supreme Court is 
inclined to affirm the decision of the Sixth Circuit . . . .”); Lawrence Hurley, To Tell the 
Truth: U.S. Top Court Mulls Omnicare Securities Case, REUTERS (Nov. 3, 2014, 3:13 PM), 
http://www.reuters.com/article/2014/11/03/usa-court-omnicare-idUSL1N0ST0SC20141103 
[http://perma.cc/UB6E-RX2N] (“Judging from questions posed during an hour of oral 
arguments, the most likely outcome is that the nine justices will throw out the appeals court 
decision.”). 
 26 Herman & MacLean v. Huddleston, 459 U.S. 375, 381–82 (1983).   
 27 Brief for U.S. as Amicus Curiae in Support of Vacatur and Remand at 11, 
Omnicare, 82 U.S.L.W. 3242 (U.S. June 12, 2014) (No. 13-435). 
 28 15 U.S.C. § 77k (2012) (emphasis added). 
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reasonably based at the time it was stated. Under this approach, liability for 
mistaken opinions would often be contingent on future events that may be 
unknowable to the issuer.29 Permitting liability by hindsight does not comport 
with the plain language of section 11. 
The second reason Omnicare should be reversed is because of its negative 
practical consequences. Lowering the bar for plaintiffs by allowing them to 
plead objective falsity alone exposes companies to expansive liability. 
Increased risk of liability means higher costs of doing business for companies, 
and these costs are passed along to the public.30 Moreover, as Justice 
Sotomayor observed during oral argument, relying on evidence of what 
happened later rather than at the time the opinion was stated means “never 
hav[ing] closure on a securities action,”31 which further raises costs to 
companies. Increased cost and risk of liability may discourage companies from 
participating in public stock offerings altogether.32 
Investors will also suffer adverse consequences because of Omnicare. 
Investors benefit from having access to information that companies voluntarily 
disclose.33 But holding companies liable whenever their opinions turn out to 
be incorrect will have a chilling effect on voluntary disclosure in registration 
statements.34 Less disclosure deprives investors of information that may 
inform their decisions to purchase securities, and it exacerbates the 
information asymmetry between investors and companies.35 Additionally, 
lowering the bar for section 11 pleading could produce an uptick in 
shareholder litigation, which has decreased stock value in the past.36 Thus, 
making it easier for investors to sue companies for mistaken opinions harms 
shareholders and companies alike. 
                                                                                                                     
 29 Brief for Petitioners at 34, Omnicare, 82 U.S.L.W. 3242 (U.S. June 5, 2014) (No. 
13-435). Legal compliance opinions are especially vulnerable to hindsight liability because 
the law changes rapidly in highly regulated industries such as health care, making it 
difficult for companies to predict how a court will rule. Id. at 35. 
 30 SEC v. Tambone, 597 F.3d 436, 453 (1st Cir. 2010) (Boudin, J., concurring). 
 31 Transcript of Oral Argument, supra note 22, at 29. 
 32 Brief for Chamber of Commerce of U.S. and Business Roundtable as Amici Curiae 
Supporting Petitioners at 21–24, Omnicare, 82 U.S.L.W. 3242 (U.S. June 12, 2014) (No. 
13-435). 
 33 See Susan B. Heyman, The Quiet Period in a Noisy World: Rethinking Securities 
Regulation and Corporate Free Speech, 74 OHIO ST. L.J. 189, 207–09 (2013); Cynthia A. 
Williams, The Securities and Exchange Commission and Corporate Social Transparency, 
112 HARV. L. REV. 1197, 1278 (1999). 
 34 Brief for Petitioners, supra note 29, at 36–37. 
 35 See Elizabeth Pollman, Information Issues on Wall Street 2.0, 161 U. PA. L. REV. 
179, 207–08 (2012). 
 36 MUKESH BAJAJ ET AL., U.S. CHAMBER INSTITUTE FOR LEGAL REFORM, ECONOMIC 
CONSEQUENCES: THE REAL COSTS OF U.S. SECURITIES CLASS ACTION LITIGATION at 35 
(Feb. 28, 2014), http://ssrn.com/abstract=2404001 [http://perma.cc/2NMT-RXX4]. 
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IV. CONCLUSION 
Companies should not be able to escape section 11 liability simply by 
framing a factual statement as an opinion—but they should not be liable when 
good faith opinions turn out to be incorrect. The Sixth Circuit’s Omnicare 
decision rests on deficient reasoning because it fails to account for differences 
between facts and opinions. It is also inconsistent with the plain language of 
section 11, which provides that objective falsity is determined at the time the 
registration statement became effective. The decision will have adverse 
consequences for companies by expanding liability, increasing costs, and 
discouraging public offerings. It will also negatively affect investors by 
chilling the disclosure of opinions and lowering stock value. For these reasons, 
Omnicare should be reversed. 
